Follow
Ihab M. Almasri
Ihab M. Almasri
Professor of Medicinal Chemistry and drug design, Al Azhar University-Gaza, Palestine
Verified email at alazhar.edu.ps
Title
Cited by
Cited by
Year
Inhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberine
IM Al-masri, MK Mohammad, MO Tahaa
Journal of enzyme inhibition and medicinal chemistry 24 (5), 1061-1066, 2009
2152009
Inhibition of hormone sensitive lipase and pancreatic lipase by Rosmarinus officinalis extract and selected phenolic constituents
Y Bustanji, A Issa, M Mohammad, M Hudaib, K Tawah, H Alkhatib, ...
J Med Plants Res 4 (21), 2235-42, 2010
1472010
Pancreatic lipase inhibition activity of trilactone terpenes of Ginkgo biloba
Y Bustanji, IM Al-Masri, M Mohammad, M Hudaib, K Tawaha, H Tarazi, ...
Journal of Enzyme Inhibition and Medicinal Chemistry 26 (4), 453-459, 2011
1212011
Pharmacophore modeling, quantitative structure–activity relationship analysis, and in silico screening reveal potent glycogen synthase kinase-3β inhibitory activities for …
MO Taha, Y Bustanji, MAS Al-Ghussein, M Mohammad, H Zalloum, ...
Journal of medicinal chemistry 51 (7), 2062-2077, 2008
1152008
Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation
Y Bustanji, MO Taha, IM Almasri, MAS Al-Ghussein, MK Mohammad, ...
Journal of enzyme inhibition and medicinal chemistry 24 (3), 771-778, 2009
1102009
Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening
MO Taha, Y Bustanji, AG Al-Bakri, AM Yousef, WA Zalloum, IM Al-Masri, ...
Journal of Molecular Graphics and Modelling 25 (6), 870-884, 2007
1052007
Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening
IM Al‐masri, MK Mohammad, MO Taha
ChemMedChem: Chemistry Enabling Drug Discovery 3 (11), 1763-1779, 2008
762008
Screening of some medicinal plants for their pancreatic lipase inhibitory potential
Y Bustanji, M Mohammad, M Hudaib, K Tawaha, IM Al-Masri, HS AlKhatib, ...
Jordan Journal of Pharmaceutical Sciences 4 (2), 81-88, 2011
642011
Eugenol reduces LDL cholesterol and hepatic steatosis in hypercholesterolemic rats by modulating TRPV1 receptor
AA Harb, YK Bustanji, IM Almasri, SS Abdalla
Scientific Reports 9 (1), 14003, 2019
632019
In vitro xanthine oxidase inhibition by selected Jordanian medicinal plants
Y Bustanji, M Hudaib, K Tawaha, M Mohammad, I Almasri, S Hamed, ...
Jordan Journal of Pharmaceutical Sciences 4 (1), 49-56, 2011
512011
Olanzapine inhibits glycogen synthase kinase-3β: An investigation by docking simulation and experimental validation
MK Mohammad, IM Al-Masri, MO Taha, MAS Al-Ghussein, HS AlKhatib, ...
European journal of pharmacology 584 (1), 185-191, 2008
482008
Inhibition of pancreatic lipase by berberine and dihydroberberine: an investigation by docking simulation and experimental validation
M Mohammad, IM Al-masri, A Issa, A Khdair, Y Bustanji
Medicinal Chemistry Research 22, 2273-2278, 2013
472013
Antioxidant, antihyperuricemic and xanthine oxidase inhibitory activities of Hyoscyamus reticulatus
MK Mohammad, IM Almasri, K Tawaha, A Issa, A Al-Nadaf, M Hudaib, ...
Pharmaceutical biology 48 (12), 1376-1383, 2010
392010
Antihyperuricemic and xanthine oxidase inhibitory activities of Tribulus arabicus and its isolated compound, ursolic acid: in vitro and in vivo investigation and docking …
YB Eman Abu-Gharbieh, Naglaa G. Shehab, Ihab M. Almasri
PLOS One 13 (8), 2018
382018
In silico screening for non‐nucleoside HIV‐1 reverse transcriptase inhibitors using physicochemical filters and high‐throughput docking followed by in vitro evaluation
Y Bustanji, IM Al‐Masri, A Qasem, AG Al‐Bakri, MO Taha
Chemical biology & drug design 74 (3), 258-265, 2009
332009
Functionalized furo [3, 2-c] coumarins as anti-proliferative, anti-lipolytic, and anti-inflammatory compounds: Synthesis and molecular docking studies
TA Fattah, A Saeed, YM Al-Hiari, V Kasabri, IM Almasri, S AlAlawi, ...
Journal of Molecular Structure 1179, 390-400, 2019
292019
Plant Products and Their Inhibitory Activity Against Pancreatic Lipase
HR Bajes, I Almasri, Y Bustanji
Revista Brasileira de Farmacognosia 30, 321-330, 2020
252020
Antilipase and antiproliferative activities of novel fluoroquinolones and triazolofluoroquinolones
S Arabiyat, V Kasabri, Y Al‐Hiari, YK Bustanji, R Albashiti, IM Almasri, ...
Chemical Biology & Drug Design 90 (6), 1282-1294, 2017
252017
Docking simulations and in vitro assay unveil potent inhibitory action of papaverine against protein tyrosine phosphatase 1B
Y Bustanji, MO Taha, IM Al-Masri, MK Mohammad
Biological and Pharmaceutical Bulletin 32 (4), 640-645, 2009
252009
Fluoroquinolones: novel class of gastrointestinal dietary lipid digestion and absorption inhibitors.
IMAM Yusuf M. Al-Hiari, Violet N. Kasabri, Ashok K. Shakya, Muhammad H ...
Med Chem Res 23 (7), 3336-3346, 2014
232014
The system can't perform the operation now. Try again later.
Articles 1–20